Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00933595 · ClinicalTrials.gov registry record · NA

Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)

A NA study of HIV Infections and Pulmonary Complications, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Completed
Registry status
NA
Development phase
1
Study location

NCT00933595 is a NA study of HIV Infections and Pulmonary Complications that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00933595, a NA study of HIV Infections and Pulmonary Complications, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

COMPLETED
Registry status
NA
Development phase
1
Study location

Study Summary

The Lung HIV goal is to facilitate the data and specimen collection efforts of eight individual HIV and pulmonary studies that operate under the direction of the NHLBI. The Lung HIV study will build on existing studies to facilitate the start-up of new projects to further the understanding of the relationship between pulmonary disease and HIV infection. There is only one clinical trial being performed in this network at Ohio State University and it will be reported here.

Interventions

  • OTHER Smoking Cessation

Study Locations (1)

Ohio

  • Ohio State University - Columbus

Trial Details

FieldValue
Start Date 2007-09
Est. Completion 2013-11
Phase NA

What the Registry Record Tells You About NCT00933595

The ClinicalTrials.gov registry entry for NCT00933595 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Smoking Cessation is the first listed.

NCT00933595 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00933595 about?

NCT00933595 is a clinical study titled "Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)". The Lung HIV goal is to facilitate the data and specimen collection efforts of eight individual HIV and pulmonary studies that operate under the direction of the NHLBI. The Lung HIV study will build on existing studies to facilitate the start-up of new projects to further the understanding of the re...

What is the current status of trial NCT00933595?

This trial is currently completed. It is a NA study. The study started on 2007-09. Estimated completion is 2013-11.

What conditions does trial NCT00933595 study?

This clinical trial studies the following conditions: HIV Infections, Pulmonary Complications.

What interventions are being tested in trial NCT00933595?

The interventions under investigation include: Smoking Cessation (OTHER).

Who is sponsoring clinical trial NCT00933595?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00933595 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.